Your shopping cart is currently empty

BRD4-IN-5 (example 51), a potent BRD4 inhibitor, exhibits K i values of 9.7 nM for the BDI_K57-E168 domain and 16.1 nM for the BDII_E352-M457 domain. This compound is utilized in cancer research [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | BRD4-IN-5 (example 51), a potent BRD4 inhibitor, exhibits K i values of 9.7 nM for the BDI_K57-E168 domain and 16.1 nM for the BDII_E352-M457 domain. This compound is utilized in cancer research [1]. |
| Targets&IC50 | BDI_K57-E168:9.7 nM (Ki), BDII_E352-M457:16.1 nM (Ki) |
| In vitro | BRD4-IN-5 (example 51) exhibits half-lives of 6 minutes, 63 minutes, and greater than 120 minutes in human, mouse, and rat liver microsomes, respectively [1]. Additionally, BRD4-IN-5 (3 days) has an EC50 of 0.101 μM in inhibiting the proliferation of the breast cancer cell line MX-1 [1]. |
| Molecular Weight | 465.45 |
| Formula | C25H21F2N3O4 |
| Cas No. | 1445993-41-8 |
| Smiles | O(C1=C(C=C(C(NC2CCOC2)=O)C=C1)C=3C4=C(C(=O)N(C)C3)NC=C4)C5=C(F)C=C(F)C=C5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.